Stifel Financial’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.84M | Sell |
|
|||||
|
2025
Q2 | $1.56M | Sell |
|
|||||
|
2025
Q1 | $1.46M | Buy |
|
|||||
|
2024
Q4 | $1.95M | Buy |
|
|||||
|
2024
Q3 | $1.2M | Buy |
|
|||||
|
2024
Q2 | $701K | Buy |
|
|||||
|
2024
Q1 | $540K | Buy |
|
|||||
|
2023
Q4 | $364K | Sell |
|
|||||
|
2023
Q3 | $394K | Sell |
|
|||||
|
2023
Q2 | $394K | Buy |
|
|||||
|
2023
Q1 | $414K | Buy |
|
|||||
|
2022
Q4 | $391K | Buy |
|
|||||
|
2022
Q3 | $247K | Buy |
|
|||||
|
2022
Q2 | $227K | Buy |
|
|||||
|
2022
Q1 | $283K | Sell |
|
|||||
|
2021
Q4 | $298K | Buy |
|
|||||
|
2021
Q3 | $321K | Sell |
|
|||||
|
2021
Q2 | $355K | Sell |
|
|||||
|
2021
Q1 | $437K | Sell |
|
|||||
|
2020
Q4 | $430K | Sell |
|
|||||
|
2020
Q3 | $452K | Buy |
|
|||||
|
2020
Q2 | $560K | Sell |
|
|||||
|
2020
Q1 | $488K | Buy |
|
|||||
|
2019
Q4 | $444K | Sell |
|
|||||
|
2019
Q3 | $635K | Buy |
|
|||||
|
2019
Q2 | $607K | Sell |
|
|||||
|
2019
Q1 | $5.77M | Sell |
|
|||||
|
2018
Q4 | $5.68M | Sell |
|
|||||
|
2018
Q3 | $8.18M | Buy |
|
|||||
|
2018
Q2 | $9M | Buy |
|
|||||
|
2018
Q1 | $6.26M | Sell |
|
|||||
|
2017
Q4 | $8.19M | Sell |
|
|||||
|
2017
Q3 | $10M | Sell |
|
|||||
|
2017
Q2 | $22.7M | Sell |
|
|||||
|
2017
Q1 | $25.9M | Buy |
|
|||||
|
2016
Q4 | $27.8M | Buy |
|
|||||
|
2016
Q3 | $29.5M | Sell |
|
|||||
|
2016
Q2 | $32.6M | Buy |
|
|||||
|
2016
Q1 | $34.1M | Sell |
|
|||||
|
2015
Q4 | $44.2M | Buy |
|
|||||
|
2015
Q3 | $35.6M | Sell |
|
|||||
|
2015
Q2 | $38.8M | Buy |
|
|||||
|
2015
Q1 | $40.2M | Sell |
|
|||||
|
2014
Q4 | $39.1M | Buy |
|
|||||
|
2014
Q3 | $33.5M | Buy |
|
|||||
|
2014
Q2 | $32M | Sell |
|
|||||
|
2014
Q1 | $38.9M | Buy |
|